← Back to Search

Other

Resistance Training for Sarcopenia

N/A
Waitlist Available
Led By Todd Manini, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Acute febrile illness in past 2 months;
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8, and week 15
Awards & highlights

Study Summary

This trial will assess whether a new method to measure muscle mass is feasible and will help researchers understand the role that muscle mass plays in functional outcomes for older adults.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8, and week 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8, and week 15 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
D3Cr Muscle Mass
Secondary outcome measures
Changes in PROMIS Physical function test
Changes in power of the knee extensors between the groups
Changes in the Short Physical Performance Battery (SPPB) between the groups
+4 more

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Persistently elevated HCT >= 54%
4%
Total serious cardiovascular adverse events
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Resistance Training group (RT)Experimental Treatment1 Intervention
The resistance training intervention will include a full body, resistance training performed three days per week. The intensity, volume, tempo, and progression will be based on the Federal Physical Activity guidelines
Group II: Successful AgingActive Control1 Intervention
The comparator group will meet for stretching and health education classes every 2-5 weeks up to 7 total visits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1190

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,333 Previous Clinical Trials
714,623 Total Patients Enrolled
6 Trials studying Sarcopenia
223 Patients Enrolled for Sarcopenia
National Institute on Aging (NIA)NIH
1,653 Previous Clinical Trials
28,004,954 Total Patients Enrolled
24 Trials studying Sarcopenia
1,577 Patients Enrolled for Sarcopenia
Todd Manini, PhDPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
121 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently open to recruitment?

"Unfortunately, clinicaltrials.gov indicates that this study is not accepting any more participants at present. The trial was initially listed on February 1st 2019 and had its last update on June 30th 2022. However, there are 107 other trials currently recruiting patients."

Answered by AI
~3 spots leftby Mar 2025